Download NURS 6630NURS 6630 Final Exam Questions And Answers latest updated and more Exams Health sciences in PDF only on Docsity!
• Question^1
1 out of 1 points
• Question^2
0 out of 1 points
• Question^3
1 out of 1 points
Mrs. Rosen is a 49-year-old patient who is experiencing fibro-fog. What does the PMHNP prescribe for Mrs. Rosen to improve this condition?
Selecte
d
Answer:
D.
All of the above An elderly woman with a history of Alzheimer’s disease, coronary artery disease, and myocardial infarction had a fall at home 3 months ago that resulted in her receiving an open reduction internal fixation. While assessing this patient, the PMHNP is made aware that the patient continues to experience mild to moderate pain. What is the PMHNP most likely to do?
Selecte
d
Answer:
A.
Order an X-ray because it is possible that she dislocated her hip. The PMHNP is caring for a patient who reports excessive arousal at nighttime. What could the PMHNP use for a time-limited duration to shift the patient’s brain from a hyperactive state to a sleep state?
Selecte
d
Answer:
B.
Benzodiazepi
• Question^4
1 out of 1 points
• Question^5
1 out of 1 points
• Question^6
1 out of 1 points
• Question^7
1 out of 1 points
nes A patient addicted to heroin is receiving treatment for detoxification. He begins to experience tachycardia, tremors, and diaphoresis. What medication will the PMHNP prescribe for this patient?
Selecte
d
Answer:
D.
Clonidine (Catapres) The PMHNP prescribes gabapentin (Neurontin) for a patient’s chronic pain. How does the PMHNP anticipate the drug to work?
Selecte
d
Answer:
A.
It will bind to the alpha-2-delta ligand subunit of voltage- sensitive calcium channels. A patient with hypersexual disorder is being assessed for possible pharmacologic treatment. Why does the PMHNP prescribe an antiandrogen for this patient?
Selecte
d
Answer:
C.
It will block testosterone. Which statement best describes a pharmacological approach to treating patients for impulsive aggression?
Selecte
d
Answer:
D.
Opioid antagonists can be used to reduce drive.
• Question^13
1 out of 1 points
• Question^14
1 out of 1 points
• Question^15
1 out of 1 points
• Question^16
1 out of 1 points
33, Mr. Peterson is obese and needs to modify his food intake. “Sometimes I think I’m addicted to food the way some people are addicted to drugs,” he says. Which statement best describes the neurobiological parallels between food and drug addiction?
Selecte
d
Answer:
A.
There is decreased activation of the prefrontal cortex. A 72-year-old male patient is in the early stages of Alzheimer’s disease. The PMHNP determines that improving memory is a key consideration in selecting a medication. Which of the following would be an appropriate choice?
Selecte
d
Answer:
D.
All of the above A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the PMHNP include when discussing the side effects with the patient?
Selecte
d
Answer:
C.
The medication can affect your blood pressure. The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which medication will the PMHNP will most likely prescribe?
Selecte
d
Answer:
A.
Strat t era The PMHNP is assessing a patient who has expressed suicidal intent and is now stating that he is hearing voices and sees people chasing him. The PMHNP identifies these symptoms to be associated with which of the following?
• Question^17
1 out of 1 points
• Question^18
1 out of 1 points
• Question^19
1 out of 1 points
• Question^20
1 out of 1 points
Selecte
d
Answer:
C.
“Bath salt” intoxicatio n An 80-year-old female patient diagnosed with Stage II Alzheimer’s has a history of irritable bowel syndrome. Which cholinergic drug may be the best choice for treatment given the patient’s gastrointestinal problems?
Selecte
d
Answer:
A.
Donepezil (Aricept) A 63-year-old patient presents with the following symptoms. The PMHNP determines which set of symptoms warrant prescribing a medication? Select the answer that is matched with an appropriate treatment.
Selecte
d
Answer
B.
Impairment in the ability to learn and retain new information is most problematic, and an appropriate treatment option would be donepezil. The PMHNP is caring for a patient with chronic insomnia who is worried about pharmacological treatment because the patient does not want to experience dependence. Which pharmacological treatment approach will the PMHNP likely select for this patient for a limited duration, while searching and correcting the underlying pathology associated with the insomnia?
Selecte
d
Answer:
D.
Non- benzodiazepine hypnotics The PMHNP is performing a quality assurance peer review of the chart of another PMHNP. Upon review, the PMHNP reviews the chart of an older adult patient in long-term care facility who has chronic insomnia. The chart indicates that the patient has been receiving hypnotics on a nightly basis. What does the PMHNP find problematic about this documentation?
• Question^25
1 out of 1 points
• Question^26
1 out of 1 points
• Question^27
1 out of 1 points
• Question^28
1 out of 1 points
appropriate prescription for the PMHNP to make?
Selecte
d
Answer:
A.
Triazola m (Halcion ) A patient with gambling disorder and no other psychiatric comorbidities is being treated with pharmacological agents. Which drug is the PMHNP most likely to prescribe?
Selecte
d
Answer:
D.
Naltrex o ne The PMHNP has been asked to provide an in-service training to include attention to the use of antipsychotics to treat Alzheimer’s. What does the PMHNP convey to staff?
Selecte
d
Answer:
D.
Both “A” & “C.”
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What does the PMHNP understand regarding the drug’s dosing profile?
Selecte
d
Answer:
B.
The patient will have one or two doses a day. Naltrexone (Revia), an opioid antagonist, is a medication that is used for which of the following conditions?
Selecte
d
Answer:
A.
Alcoholi s m
• Question^29
1 out of 1 points
• Question^30
1 out of 1 points
• Question^31
1 out of 1 points
• Question^32
1 out of 1 points
Kevin is an adolescent who has been diagnosed with kleptomania. His parents are interested in seeking pharmacological treatment. What does the PMHNP tell the parents regarding his treatment options?
Selecte
d
Answer:
A.
“Naltrexone may be an appropriate option to discuss.” The PMHNP is caring for a patient with chronic insomnia who would benefit from taking hypnotics. The PMHNP wants to prescribe the patient a drug with an ultra-short half-life (1–3 hours). Which drug will the PMHNP prescribe?
Selecte
d
Answer:
C.
Triazola m (Halcion ) A patient recovering from shingles presents with tenderness and sensitivity to the upper back. He states it is bothersome to put a shirt on most days. This patient has end stage renal disease (ESRD) and is scheduled to have hemodialysis tomorrow but states that he does not know how he can lie in a recliner for 3 hours feeling this uncomfortable. What will be the PMHNP’s priority?
Selecte
d
Answer:
C.
Prescribe lidocaine 5% The PMHNP wants to use a symptom-based approach to treating a patient with fibromyalgia. How does the PMHNP go about treating this patient?
Selecte
d
Answer
C.
Matching the patient’s symptoms with the malfunctioning brain circuits and neurotransmitters that might mediate those symptoms
• Question^37
0 out of 1 points
• Question^38
1 out of 1 points
• Question^39
1 out of 1 points
• Question^40
1 out of 1 points
The PMHNP evaluates a patient presenting with symptoms of dementia. Before the PMHNP considers treatment options, the patient must be assessed for other possible causes of dementia. Which of the following answers addresses both possible other causes of dementia and a rational treatment option for Dementia?
Selecte
d
Answer:
A.
Possible other causes: hypothyroidism, Cushing’s syndrome, multiple sclerosis Possible treatment option: memantine The PMHNP is assessing a patient who presents with elevated levels of brain amyloid as noted by positron emission tomography (PET). What other factors will the PMHNP consider before prescribing medication for this patient, and what medication would the PMHNP want to avoid given these other factors?
Selecte
d
Answer:
D.
Both “A” & “B” The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of atypical antipsychotics?
Selecte
d
Answer:
C.
The doses are based on achieving 60% D2 receptor occupancy. The PMHNP is caring for a patient who experiences too much overstimulation and anxiety during daytime hours. The patient agrees to a pharmacological treatment but states, “I don’t want to feel sedated or drowsy from the medicine.” Which decision made by the PMHNP demonstrates proper knowledge of this patient’s symptoms and appropriate treatment options?
Selected A.
• Question^41
1 out of 1 points
• Question^42
1 out of 1 points
• Question^43
1 out of 1 points
• Question^44
1 out of 1 points
Answer: Avoiding^ prescribing^ the^ patient^ a^ drug^ that
blocks H1 receptors Which patient will receive a lower dose of guanfacine?
Selecte
d
Answer:
D.
Patient with kidney disease A patient diagnosed with obsessive compulsive disorder has been taking a high-dose SSRI and is participating in therapy twice a week. He reports an inability to carry out responsibilities due to consistent interferences of his obsessions and compulsions. The PMHNP knows that the next step would be which of the following?
Selecte
d
Answer:
A.
Decrease his SSRI and add buspirone (Buspar). The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the PMHNP include in the teaching?
Selecte
d
Answer:
A.
The second dose should be taken at lunch. The PMHNP is assessing a patient who will be receiving phentermine (Adipex- P)/topiramate (Topamax) (Qsymia). Which of the following conditions/diseases will require further evaluation before this medication can be prescribed?
Selecte
d
Answer:
C.
Cardiovascular disease
• Question 45
• Question^50
1 out of 1 points
• Question^51
1 out of 1 points
• Question^52
1 out of 1 points
• Question^53
1 out of 1 points
and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will the PMHNP select?
Selecte
d
Answer:
A.
Lithium (Lithane ) The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices when she prescribes the following dose:
Selecte
d
Answer:
A.
The child will be prescribed 2.5 mg. Mrs. Kenner is concerned that her teenage daughter spends too much time on the Internet. She inquires about possible treatments for her daughter’s addiction. Which response by the PMHNP demonstrates understanding of pharmacologic approaches for compulsive disorders?
Selecte
d
Answer
D.
“There are no evidence-based treatments for Internet addiction, but there are behavioral therapies your daughter can try.” A 43-year-old male patient is seeking clarification about treating attention deficit hyperactivity disorder (ADHD) in adults and how it differs from treating children, since his son is on medication to treat ADHD. The PMHNP conveys a major difference is which of the following?
Selecte
d
Answer:
D.
Comorbidities are more common in adults, impacting the prescription of additional agents. A 71-year-old male patient comes to an appointment with his 65-year-old wife. They are both having concerns related to her memory and ability to recognize faces. The PMNHP is considering prescribing memantine (Namenda) based on the following symptoms:
• Question^54
0 out of 0 points
• Question^55
1 out of 1 points
• Question^56
1 out of 1 points
• Question^57
1 out of 1 points
Selecte
d
Answer:
C.
Amnesia, apraxia, agnosia
When completing this exam, did you comply with Walden University’s Code of
Conduct including the expectations for academic integrity?
Selected Ye
Answer: s
The PMHNP is working with the student to care for a patient with diabetic peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not consistently useful in treating this particular patient’s pain. What is the best response by the PMHNP?
Selecte
d
Answer:
B.
“SSRIs only increase serotonin levels.” The PMHNP is treating a patient for fibromyalgia and is considering prescribing milnacipran (Savella). When prescribing this medication, which action is the PMHNP likely to choose?
Selecte
d
Answer:
C.
Split the daily dose into two doses after the first day. A patient is being prescribed bupropion and is concerned about the side effects. What will the PMHNP tell the patient regarding bupropion?
Selecte
d
Answer:
C.
It can cause cardiac arrhythmias.
• Question^63
1 out of 1 points
• Question^64
1 out of 1 points
• Question^65
1 out of 1 points
• Question^66
1 out of 1 points
A 75-year-old male patient diagnosed with Alzheimer’s disease presents with agitation and aggressive behavior. The PMHNP determines which of the following to be the best treatment option?
Selecte
d
Answer:
D.
Citalopram (Celexa) or Escitalopram (Lexapro) An 8-year-old patient presents with severe hyperactivity, described as “ants in his pants.” Based on self-report from the patient, his parents, and his teacher; attention deficit hyperactivity disorder (ADHD) is suspected. What medication is the PMNHP most likely to prescribe?
Selecte
d
Answer:
A.
Methylphenidate (Ritalin, Concerta) The PMHNP is providing a workshop for pediatric nurses, and a question is posed about noradrenergic agents to treat ADHD. Which of the following noradrenergic agents have norepinephrine reuptake inhibitor (NRI) properties that can treat ADHD?
Selecte
d
Answer:
D.
Both “A” & “C” A patient with chronic back pain has been prescribed a serotonin- norepinephrine reuptake inhibitor (SNRI). How does the PMHNP describe the action of SNRIs on the inhibition of pain to the patient?
Selecte
d
Answer
A.
“The SNRI can increase noradrenergic neurotransmission in the descending spinal pathway to the dorsal horn.” An opioid-naive patient is taking MS Contin (morphine sulfate) to treat his pain that is
• Question^67
1 out of 1 points
• Question^68
1 out of 1 points
• Question^69
1 out of 1 points
• Question^70
1 out of 1 points
secondary to cancer. Under what circumstances would the PMHNP order naloxone (Narcan) IM/SQ?
Selecte
d
Answer:
D.
The patient’s vital signs are 98.4F temp, 88 pulse, 104/62 blood pressure, and 8 respirations. Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the patient with psychosis and aggression?
Selecte
d
Answer:
A.
There is too high a risk of serious adverse side effects. The PMHNP understands that bupropion (Wellbutrin) is an effective way to assist patients with smoking cessation. Why is this medication effective for these patients?
Selecte
d
Answer:
C.
Bupropion (Wellbutrin) blocks dopamine reuptake, enabling more availability of dopamine. An 18-year-old female with a history of frequent headaches and a mood disorder is prescribed topiramate (Topamax), 25 mg by mouth daily. The PMHNP understands that this medication is effective in treating which condition(s) in this patient?
Selecte
d
Answer:
A.
Migrai n es The PMHNP is teaching a patient with a sleep disorder about taking diphenhydramine (Benadryl). The patient is concerned about the side effects of the drug. What can the PMHNP teach the patient about this treatment approach?
Selecte
d
Answer:
B.
“It can cause blurred
• Question^76
1 out of 1 points
The PMHNP is assessing a female patient who has been taking lamotrigine (Lamictal) for migraine prophylaxis. After discovering that the patient has reached the maximum dose of this medication, the PMHNP decides to change the patient’s medication to zonisamide (Zonegran). In addition to evaluating this patient’s day-to-day activities, what should the PMHNP ensure that this patient understands?
Selecte
d
Answer:
D.
This medication has unwanted side effects such as sedation, lack of coordination, and drowsiness. The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the PMHNP exhibits proper care for this patient? </p?
Selecte
d
Answer:
C.
Titrating the dose by increasing it every 5–7 days
